Roche

ROG.SW Mega Cap

Healthcare · Drug Manufacturers - General

Updated: Apr 5, 2026, 00:03 UTC

CHF 322.30

+0.5% today

52W: CHF 231.90 – CHF 374.90

52W Low: CHF 231.90 Position: 63.2% 52W High: CHF 374.90

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

20.11x

Price-to-Earnings

Forward P/E

14.82x

Forward Price/Earnings

P/S Ratio

4.05x

Price-to-Sales

EV/EBITDA

11.57x

Enterprise Value/EBITDA

Div. Yield

3.03%

Annual dividend yield

Market Cap

$256.4B

Market Capitalization

Revenue Growth

-0.4%

YoY Revenue Growth

Profit Margin

20.33%

Net profit margin

ROE

37.27%

Return on Equity

Beta

0.21

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

1,170,679

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

19 analysts

Avg. Price Target

CHF 364.79

+13.18% upside

Target Range

CHF 230.00 – CHF 428.00

🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →

About the Company

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Sector: Healthcare Industry: Drug Manufacturers - General Country: Switzerland Exchange: EBS